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Characterizing the cognitive declines associated with aging, and differentiating them
from the effects of disease in older adults, are important goals for human neuroscience
researchers. This is also an issue of public health urgency in countries with rapidly aging
populations. Progress toward understanding cognitive aging is complicated by numerous
factors. Researchers interested in cognitive changes in healthy older adults need to
consider these complexities when they design and interpret studies. This paper addresses
important factors in study design, patient demographics, co-morbid and incipient medical
conditions, and assessment instruments that will allow researchers to optimize the
characterization of healthy participants and produce meaningful and generalizable research
outcomes from studies of cognitive aging. Application of knowledge from well-designed
studies should be useful in clinical settings to facilitate the earliest possible recognition
of disease and guide appropriate interventions to best meet the needs of the affected
individual and public health priorities.
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INTRODUCTION
The definitional boundaries of cognitive aging remain contro-
versial and are likely to elude consensus for the foreseeable
future. The ambiguities stem from the wide range of goals and
scientific questions arising from different lines of inquiry. For
example, epidemiological studies examining the effects of disease
typically employ brief health histories and screening examina-
tions applicable to large cohorts of people, whereas experimental
studies use smaller samples and focus on a limited number of
cognitive domains, In contrast, the clinician working in a med-
ical setting evaluates individuals, each of whom present with a
unique chronologic, cultural, psychosocial, educational, genetic,
and medical history and a decision has to be made whether the
symptoms or signs the patient expresses are “normal” (i.e., do not
require evaluation and intervention) or abnormal.
An important goal for research in cognitive aging is to better
characterize healthy aging to assist clinical decision-making about
cognitive changes in older patients. TheMcKnight Brain Research
Foundation therefore commissioned a working group to address
challenges and opportunities in cognitive aging research and pro-
vide practical information to investigators that can improve the
pace, quality, and clinical utility of research in the field. This paper
is not intended to be comprehensive or a systematic review of
all the factors that might affect cognitive aging. Readers inter-
ested in more exhaustive treatments of this broad, complex, and
well-researched field may find the volumes edited by Hofer and
Alwin (2008) and Craik and Salthouse (2008) useful. Rather, we
intend to provide a brief guide to factors that should be consid-
ered as a researcher classifies an older human research participant
as “healthy” or not. Additionally we provide a brief review of
clinically oriented instruments frequently used to characterize the
cognitive state of older research participants.
CONSIDERING CROSS-SECTIONAL vs. LONGITUDINAL
METHODS
The major temporal approaches to understanding cognitive aging
are cross sectional and longitudinal designs. Cross sectional
approaches can be conducted on large samples across many ages
efficiently and at lower cost, but have limitations. The most
important limitation from an epidemiologic perspective is that
causal relationships between an exposure and an outcome can-
not be determined. In addition, such studies are vulnerable to
cohort effects whereby different age groups have varying life expe-
riences (e.g., early life nutrition or educational methods). As one
example, Laursen (1997) found that individuals of a given age
performed better on cognitive tests than people who took the
same tests when they were the same age, only a decade earlier.
Cross sectional studies therefore cannot clearly define aging alone
as the source of group differences, but merely identify associ-
ations between age and performance. Cross sectional methods
also account poorly for the effects of variability in individual
performance unrelated to aging. The complexity of this issue is
illustrated by results from, the Cambridge Project for Later Life,
in which 28% of participants showed improved cognitive perfor-
mance over a mean 28-month follow-up period (Brayne et al.,
1992).
Longitudinal studies are better at clarifying the role of aging
as the source of individual differences over time, but longitudinal
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designs are dependent on participants’ ability to return for follow-
up evaluation. This can be particularly challenging in elderly
samples because individuals with advanced age, lower education
and SES, in worse physical health, and undergoing stress, as well
as those who are more likely to have depression tend to drop out
of studies (Nevid et al., 1996; Burg et al., 1997; Laursen, 1997;
Mihelic and Crimmins, 1997; Schmand et al., 1997; Desmond
et al., 1998; Hoeymans et al., 1998; Levin et al., 2000). Therefore,
longitudinal studies are susceptible to bias associated with self-
censorship. Furthermore, if participants who do not return for
follow up evaluation differ from those who do, an attrition bias
will confound the research. This is especially problematic for
studies examining more subtle forms of cognitive impairment.
An attrition bias will not only limit the study’s generalizabil-
ity, but can exclude individuals intended to be the major study
focus (Levin et al., 2000). Therefore, adjustments for the effects
of differential attrition should be included in longitudinal stud-
ies to avoid underestimates of the true rate of decline (Park et al.,
2003).
Another challenge faced by researchers using either method
is subclinical disease. Conceptual approaches for major age-
related diseases that affect cognition, including Alzheimer’s dis-
ease, Parkinson’s disease, and vascular cognitive impairment
(VCI) now explicitly recognize pre-symptomatic stages, during
which the disease causes meaningful damage to the brain with-
out bringing the individual to medical attention (Gorelick et al.,
2011). As a result, research participants classified as “normal”
may in fact be experiencing subtle changes in higher-order cog-
nitive functions, or employing compensatory mechanisms that
could influence research conclusions about what is normal. The
nature of this experimental challenge is exemplified by studies
showing anatomic and functional imaging abnormalities among
people with a known genetic risk factor for Alzheimer’s dis-
ease but who exhibit normal cognitive performance (Reiman
et al., 1996; Alexander et al., 2012). Similarly, cardiovascular or
stroke risk factors may lead to damage that results in significant
declines in cognitive performance that may remain undetected
(Llewellyn et al., 2008). For example, participants with subclinical
white matter lesions, subclinical infarcts, ormicrobleeds may have
subtle changes in cognitive performance in particular domains
(e.g., executive function) and be within the normative range for
others.
Longitudinal analysis can also be confounded by “right cen-
soring,” whereby participants who are normal at the last obser-
vation are considered to be unaffected by the condition under
study. This phenomenon is illustrated by the MoVIEs project,
in which observation for dementia incidence in 1298 partici-
pants was ended after ten years. By the end of the observation
period, dementia had developed in 199 of the participants; for
the other 1099 participants, death, drop-out, or completion of the
study was the end-point for observation and they were classified
as non-demented (Ganguli et al., 2000). Given annual demen-
tia incidence rates of 8–40% among the non-demented oldest
old (Peltz et al., 2011), and a consensus that Alzheimer’s disease
pathology may be present for many years before the first symp-
toms emerge (Albert et al., 2011), the assumption that the 1099
“survivors” in the MoVIES cohort were truly disease-free may be
inaccurate. Although not practical for most researchers, future
analyses conducted on large longitudinal data sets (like MoVIES
or the Framingham cohort) should include analytic methods
account for expected incident dementia rates.
HETEROGENEITY OF SAMPLES
In attempting to characterize healthy aging samples, researchers
face a myriad of complicating factors. Age itself alters the fre-
quency and rate of cognitive change, with the oldest old showing
both a more impaired baseline and a more rapid decline on most
neuropsychological measures (Park et al., 2003). Unfortunately,
cognitive abilities have been the least well studied in the oldest age
groups and there is a striking lack of normative standards to eval-
uate the very old. As a result, investigators studying participants
older than 80 years will turn to norms developed for younger
cohorts. Mayo’s Older American Normative Studies (MOANS;
Lucas et al., 2005) andWhittle and colleagues (2007) study exam-
ining the oldest old (90+ years) provide valuable normative data
on select subtests. Given census data indicating that the popula-
tion of individuals aged 85 years and older is the fastest growing
age group, there will continue to be a pressing need to develop
age-appropriate and age-normed tests. In the interim, investiga-
tors carrying out research on this age group should incorporate
measures that have the necessary age corrections or make sure the
study design includes an age matched control group (Levin et al.,
2000; Manly and Echemendia, 2007; Levin, 2009).
CULTURE AND LANGUAGE
Many studies attempt to limit the effects of culture and language
on their outcomes. While there is general agreement that no tests
are “culture-free,” measures have been developed to minimize
cultural bias. There are two types of culture fair tests. The first
employs items that are assumed to be familiar to all individuals
from a variety of ethnic backgrounds. The second type eliminates
the need for expressive language, i.e., the test utilizes geomet-
ric or spatial stimuli and can be administered without verbal
demands through the use of gestures or demonstration. However,
cultural factors are much more pervasive than language alone.
Culture and educational achievement significantly influence per-
formance even on presumably non-verbal neuropsychological
tests (Rosselli and Ardila, 2003). Performance on culture fair tests
is also affected by enriched or impoverished environments and
there is research showing even larger group differences with non-
verbal tests compared to verbal tests (Geisinger, 2003). Accurate
cultural adaptation of cognitive tests is extremely labor intensive
and may involve alteration of test instructions, revision of both
verbal and non-verbal test content, and changes in item order
(Malda et al., 2008).
RACE AND ETHNICITY
There is general agreement that most cognitive measures used in
the US were standardized on Caucasian samples and are there-
fore biased, rendering them not appropriate in either clinical
or research settings that focus on linguistically and culturally
diverse populations. US census projections show that immigra-
tion will be the driving force behind future population growth,
a finding that underscores the need to develop measures that
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are sensitive to growing racial and ethnic diversity. Furthermore,
understanding cognitive aging in this context is complicated by
research showing that there are a host of social/environmental
factors that also influence test performance, such as the dura-
tion of residence and experiences in the US, the country and
age where an individual learned English, their primary language,
and reading ability (Harris et al., 2003; Manly, 2005). Altering
test score cut-points for defining normal performance among
minority populations is not always useful (Parker and Philp,
2004). For example, Boone and colleagues (2007) used a data
set derived from Caucasians, African Americans, Hispanics, and
Asians referred to an outpatient neuropsychology clinic in Los
Angeles to examine associations between ethnicity and perfor-
mance on common neuropsychological measures. Although the
groups were similar in the nature and severity of their pre-
senting illnesses, and the test scores were adjusted for age and
education, significant ethnic group differences were noted on
one-third of neuropsychological measures, which understand-
ably included naming, but also included tests with less linguistic
loading like digit span, visual construction, and non-verbal pro-
cessing speed. There is no consensus on how to best address
the influence of cultural heterogeneity on assessment of cog-
nition and there are no empirically based guidelines (Manly
and Echemendia, 2007). However, measures of literacy are valu-
able indicators of quality of education and can help account for
race/ethnic and cultural differences in studies of cognitive aging.
For example, in a Northern Manhattan study sample, African
Americans elders performed worse than whites across a number
of neuropsychological tests when matched for years of educa-
tion, but the effect was much smaller, and in most cases no
longer significant, after adjusting for reading ability (Manly et al.,
2002).
LIFE ACHIEVEMENT
Variability in cognitive performance within age cohorts, associ-
ated with factors such as, education, culture, and race/ethic back-
ground, has led to the concept of brain and cognitive reserves,
theoretical constructs representing, respectively, the anatomical
and functional factors that protect the brain from aging and
pathology (Stern, 2002, 2009). In the case of cognitive reserve,
a growing body of data suggests that educational and occupa-
tional attainments, as well as a stimulating lifestyle, provide resis-
tance against the effects of aging and diverse pathologies, such
as vascular damage and Alzheimer disease (Stern et al., 1994).
Indeed, both higher education and occupational attainment have
been associated with slower cognitive decline and a lower risk
of dementia in the elderly (White et al., 1994; Evans et al.,
1997; Valenzuela and Sachdev, 2006). An active lifestyle—one
that includes intellectual stimulation, increased physical activ-
ity and participation in social activities—has been associated
with better neuropsychological test performance in later years
and a lower risk of dementia (Scarmeas et al., 2001; Verghese
et al., 2003). Functional neuroimaging studies have confirmed the
hypothesis that such protective factors may achieve their effect
by creating more efficient cognitive networks and promoting
neural compensation (Steffener et al., 2011). By accounting for
these factors, cognitive aging researchers may better understand
individual differences in cognitive trajectories. This is supported
by data from a confirmatory factor analysis showing that cogni-
tive reserve can be identified as a separate factor of individual
differences beyond traditional cognitive domains such as mem-
ory, executive function, and psychomotor speed (Siedlecki et al.,
2009). On the other hand, it is important to note that variables
thought to explain brain reserve capacity, such as age, innate
intelligence, genetic factors, head size, and brain volume—the
latter two used as proxies for the number of neurons and the
density of synapses—influence not only cognitive outcomes but
also the very elements of cognitive reserve such as education
and occupational attainment (e.g., greater intelligence influences
educational and occupational attainment) (Schofield et al., 1997;
Whalley et al., 2000; Reed et al., 2010). Thus, studies of cognitive
aging are likely to benefit from including measures that account
as fully as possible for brain and cognitive reserve (Jones et al.,
2011).
A host of other socio-demographic factors have been linked
to healthy cognitive and physical aging. The benefits of physical
exercise, healthy nutrition and lifestyle and close interpersonal
relationships are well described and have been reviewed else-
where (Ball and Birge, 2002). An important point is that while
some studies have examined the individual contribution of each
factor, they are not randomly distributed in the population and
tend to occur together in the same individual (Poortinga, 2007).
Therefore, a careful assessment of these psychosocial and behav-
ioral factors is an important consideration in both research
subject selection and clinical diagnostic evaluation.
SENSORY FUNCTION AND COGNITION
The aging process has a significant impact on sensory func-
tions, which then can adversely—but indirectly—affect cogni-
tion. Older adults show considerably more variability in visual
and auditory function than the young (Baltes and Lindenberger,
1997). Downstream effects of sensory loss can mimic the pres-
ence or mask the severity of primary cognitive changes associated
with brain aging. There is also evidence suggesting that age-
related changes in sensory processing and cognition may share
a common pathophysiologic basis (Baltes and Lindenberger,
1997).
Age-related changes in the optical properties of the eyes are
substantial. Ocular disorders, including cataracts and glaucoma,
are extremely prevalent in the aging population; they lead to sub-
tle visual processing changes in domains like contrast sensitivity
that are not routinely assessed in cognitive studies (Jackson and
Owsley, 2003). However, when the visual changes of cataracts
are simulated, they lead to measurable cognitive performance
decrements (Wood et al., 2010). Vision in older adults fluctuates,
especially in response to the amount of illumination; when visual
performance is low, there are associated deficits in memory and
other cognitive functions (Weatherbee et al., 2009).
As with vision, there are age-related impairments arising from
the auditory sensory apparatus. Poor hearing, especially for the
higher frequencies, is a nearly ubiquitous finding among older
adults. Like vision, it shows accelerating decline in older age
cohorts. Hearing loss is associated with lower Mini–Mental State
Examination (MMSE; Folstein et al., 1975) scores and lower
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performance on neuropsychological tests of memory and exec-
utive function (Lin et al., 2011).
The NIH Toolbox initiative (see overview paper by Roberson
et al., this volume) has recognized the importance of sensory
assessments in understanding cognitive ability, but unfortunately
it includes only acuity as a direct test of visual performance.
This is likely to underestimate the contribution of visual impair-
ment relative to cognition in aging (Jackson and Owsley, 2003).
Experimenters can use a number of techniques beyond screen-
ing for visual and auditory deficits to ameliorate the effect of
age-related sensory deficits. Good visual stimulus designs avoid
low contrast or luminance, short wavelength colors (violet and
blue), and high spatial or temporal frequencies (Scialfa, 2002).
Researchers seeking additional information on the origins and
effects of age-related sensory function on cognition may find
Schneider and Pichora-Fuller’s (Schneider and Pichora-Fuller,
2000) extensive review helpful.
EFFECT OF COMORBIDITIES
The boundaries between risk factors for cognitive decline and
causes of that decline are becoming increasingly blurred. This is
true for both genetic factors and illness states that predispose to
the development of dementia. The ε-4 allele of Apolipoprotein E
(APOE 4) is well recognized as a genetic risk factor for sporadic
Alzheimer disease. However, middle-aged asymptomatic APOE
4 carriers in the Framingham Offspring Cohort showed a more
rapid decline in logical memory performance compared to non-
carriers, without showing concomitant changes in MRI markers
of brain aging (Debette et al., 2009). The following paragraphs
address common comorbidities known to influence cognition
and dementia risk.
CARDIOVASCULAR FACTORS
Modifiable cardiovascular risk factors such as hypertension, dia-
betes, dyslipidemia, smoking, and obesity are nearly ubiquitous
among older adults in developed nations and have been asso-
ciated to varying degrees with greater risk of dementia. Less is
known about the effect of these factors on cognitive decline in
normal aging, especially in the oldest old where hypertension
appears to be the most prevalent risk factor and has been associ-
ated with worse cognitive performance among the non-demented
(Peltz et al., 2012). Further, it is important to note that even with-
out structural brain changes, cardiovascular risk factors have been
associated with worse cognition. Participants with hypertension
in the Framingham Offspring Cohort showed greater declines on
executive function tests (Trailmaking Tests), an observation that
was not altered by adjusting for markers of white matter ischemia
on MRI or baseline education (Debette et al., 2011). The same
study found that midlife obesity was associated with more rapid
decline in Trailmaking Test performance. Thus, it is important to
consider cardiovascular risk factor status when designing studies
of cognitive aging.
MOOD DISORDERS
Research examining mood symptoms among elderly non-
demented individuals has shown that about one third experience
low level depressive symptoms, referred to as subthreshold or
subsyndromal depression (Lyness et al., 2007) However, because
affected individuals may not recognize or voice such men-
tal health symptoms, identifying these concernsin study sam-
ples can be quite difficult. There are several reasons why it is
important to carefully assess mood state in studies of cogni-
tion in aging. First, depression, anxiety, and apathy can directly
impact cognitive performance, masking a subject’s true abil-
ity. For example, depression has significant effects on episodic
memory and executive function (Austin et al., 2001), which
are frequently domains of interest in studies of cognitive aging.
Second, extreme symptoms are not always apparent on screen-
ing instruments like the Geriatric Depression Scale (Sheikh and
Yesavage, 1986) or the revised Beck Depression Inventory (Beck
et al., 1996). These scales are used frequently, but reliance on a
cut score to identify a mood state sufficient to affect cognition
has shortcomings. Individuals may endorse a severe symptom
on a questionnaire but still fall below the cut score necessary
for a clinical diagnosis. This is particularly true among partic-
ipants with more minor depressive syndromes, for whom false
negative rates on this type of scale can exceed 20% (Gallagher
et al., 1983). Therefore, it may be valuable to examine the indi-
vidual items on mood questionnaires as well as the total score.
Third, changes in mood states may be an important marker of
early or incipient cognitive decline and thereby undermine con-
clusions about what is “normal” cognition (Rosenberg et al.,
2010).
DRUGS AND ALCOHOL
Although often not assessed in detail, older adults are especially
at risk for potential complications and disorders associated with
the use of prescription and over the counter drugs, including
alcohol (Powell, 2004). A large proportion of older adults are
on multiple medications for systemic diseases, many of which
have the potential to interfere with cognition. Researchers and
clinicians need to be aware of possible drug and alcohol effects
when assessing cognition in the elderly. A thorough review of
medications, recreational drugs, and alcohol usage will allow
investigators to statistically control for potential confounders
that may interfere with the cognitive abilities under study. For
instance, there is an extensive literature demonstrating cognitive
impairments following long-term use of antianxiety drugs, espe-
cially the benzodiazepines (Green, 2000; Powell, 2004). Similarly,
a community-based study conducted in France revealed that 80%
of an elderly sample who chronically used anticholinergic drugs,
like those frequently used to treat urinary incontinence, showed
detectable but non-progressive cognitive impairments (Ancelin
et al., 2006).
SCREENING TECHNIQUES
The preceding sections have discussed general considerations in
study design and subject selection. At a more practical level,
researchers must characterize the cognitive performance of their
participants as appropriate for age, or as impaired. While many
studies will use detailed experimental approaches to assess spe-
cific cognitive domains, most investigations use brief measures
that include performance across a range of cognitive skills to
determine subject eligibility.
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Dozens of standardized tests have been developed to screen for
abnormalities in human cognition. However, their identified pur-
pose has generally been either to identify, or exclude, individuals
with disease-based alterations in cognition, such as demen-
tia, rather than identify patterns of change associated with the
aging process. The American Psychological Association Practice
Guideline for Evaluation of Dementia and Age-Related Cognitive
Decline addresses the limitations of standardized tests for detect-
ing age-related changes in cognition and makes several general
recommendations regarding limitations of standardized tests for
detecting age-related changes in cognition (see http://www.apa.
org/practice/guidelines/dementia.aspx#). The guideline suggests
that cut-scores on screening tests offer reasonable sensitivity to
dementia, but perform less well in classifying the earliest cognitive
changes associated with “pre-clinical dementia.”
IN PERSON TESTING
The MMSE, developed in the 1970 s, is the most widely employed
instrument for assessing cognition in the elderly (Folstein et al.,
1975). It is short, consisting of 11 questions totaling 30 points,
and performance is not timed. Although originally designed for
psychogeriatric patients, the MMSE is currently used as a screen-
ing instrument for patients with a wide range of neurologic and
medical disorders. Its major uses are to serve as a screen for gen-
eral cognitive impairment, assess the degree of impairment and
prospectively monitor change. A normal MMSE provides good
utility for excluding dementia in community and primary care
settings, with negative predictive values in the 95–98% range
(Mitchell, 2009). Unfortunately, the instrument is not sensitive
for discriminating between age-related cognitive change, mild
cognitive impairment and early dementia (Ismail et al., 2010).
There are clear advantages to using the MMSE, which include
its straightforward administration, the use of published cut-
scores as well as age and education corrected norms, and numer-
ous international translations. However, there are also limitations,
the most significant being that the MMSE is frequently used as a
diagnostic measure and not, as originally intended, as a screen-
ing instrument. Other limitations of the MMSE include its heavy
reliance on verbal abilities, (penalizing those with language prob-
lems and limited education) and a lack of agreement with regard
to the best cut score.
Other screening tools have been developed that address some
of the MMSE limitations in identifying milder cognitive impair-
ments. These include the Modified MMSE (3MS; Teng and Chui,
1987), Montreal Cognitive Assessment (MoCA; Nasreddine et al.,
2005), the St. Louis University Mental Status Test (SLUMS; Tariq
et al., 2006). The 3MS, an adaptation of the MMSE, adds four
items and uses an expanded scoring system (0–100). The MoCA
was specifically developed as a screen for mild cognitive impair-
ment in the general population and has been shown to have
excellent test–retest reliability, inter-rater reliability, and con-
vergent validity. Another strength is that the MoCA measures
a broader range of cognitive abilities than the MMSE, includ-
ing executive function. Like the MMSE, the SLUMS is built
around 11 items and a 30-point scoring system. However, it
showed greater sensitivity to milder cognitive impairments in
people not meeting dementia criteria. Although each has been
compared to the MMSE, further head-to-head testing among
these alternatives has not been systematically studied. Additional
instruments in less common use for studies of cognitive aging
were recently reviewed by Ismail and colleagues (2010). Based
on their intended role to identify illness (rather than characterize
age-related change) and the many variables that influence per-
formance within age cohorts noted above, there appears to be
an insufficient data to make an evidence-based recommendation
for a specific screening instrument to establish normal cognition
across aging cohorts.
Mental status screening instruments are not meant to take
the place of a more thorough diagnostic work up in clini-
cal settings. A carefully selected neuropsychological test bat-
tery will improve diagnostic sensitivity and specificity while
providing a comprehensive evaluation of mental status func-
tion. Guidelines for selecting individual cognitive domains and
relevant assessment examples that could be incorporated into
a comprehensive test battery were recently published by the
DSM-V Neurocognitive Work Group (Ganguli et al., 2011).
The DSM-V, to be published in 2013, will use the new diag-
nostic category Neurocognitive Disorders, to replace the older
category of “Delirium, Dementia and Amnestic, and Other
Geriatric Disorders.” This newer diagnostic entity will be fur-
ther subdivided into three syndromes: Delirium, Major Cognitive
Disorder, and Minor Cognitive Disorder. The six principal cog-
nitive domains that are recommended for documenting and
quantifying the degree of impairment include complex attention,
executive ability, learning and memory, expressive and recep-
tive language, visuoconstructional-perceptual ability and social
cognition.
TELEPHONE SCREENING
Some investigators studying variables relevant to cognitive aging
need to classify the cognitive state of participants without in-
person assessments. The Telephone Interview of Cognitive Status-
Modified (TICS-m) is a mental state assessment designed to
screen for cognitive impairment by telephone. The TICS-m
showed modest correlations with a comprehensive neuropsycho-
logical assessment in older persons without dementia (Van Den
Berg et al., 2012). However, its utility for identifying subtle decre-
ments in individuals is limited and it may misclassify as many as
40% of participants, typically in the direction of assigning demen-
tia diagnosis to mild deficits (Cherbuin et al., 2008). This may be
especially problematic for researchers studying the subtle changes
associated with cognitive aging. The Memory Impairment Scale
(MIS; Buschke et al., 1999) is a neuropsychological screening test
that was adapted for telephone administration, retaining good
psychometric properties. In a sample of 300 participants (mean
age 80) with 9% dementia prevalence the MIS showed sensitiv-
ity of 78%, specificity of 93% and a misclassification rate of 8%
(Lipton et al., 2003).
SELF-RATED AND INFORMANT-REPORTED SCALES
Subjective memory (or cognitive) complaints (SMC) are com-
mon in older adults, being reported by up to 88% of individuals
older than 85 years (Larrabee and Crook, 1994). This is impor-
tant because SMC have been associated with a greater risk of
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dementia in some studies, while data is limited regarding age-
related cognitive decline (Waldorff et al., 2012). Thus, SMC do
not necessarily reflect meaningful variations from normal per-
formance for age. Cherbuin and colleagues (2008) conducted a
systematic review of available self- and informant-report instru-
ments to assess cognitive abilities. Only two instruments, the
Concord Informant Dementia Scale (CIDS; Waite et al., 1998)
and the Informant Questionnaire on Cognitive Decline in the
Elderly (IQCODE; Jorm, 2004) met all selection criteria for their
analysis. The CIDS and IQCODE as well as the MIS (see above)
had a misclassification rate and negative predictive value better
than the MMSE in samples with dementia prevalence around
10%; additionally, the sensitivity and specificity of the three
instruments were similar to those of the MMSE (Cherbuin et al.,
2008).
The CIDS is a 31-item instrument that assesses changes in
cognition over a 5 year reference period. A 12-item short form
(SCIDS;Waite et al., 1998) is also available. Both CIDS and SCIDS
scores discriminate between demented and non-demented peo-
ple in a community sample and correlate with neuropsychological
test performance; furthermore, they appear to be less influenced
by educational level than MMSE (Waite et al., 1998).
The IQCODE is a more widely known questionnaire with
numerous translations to other languages. The instrument orig-
inally consisted of 26 questions; a shorter 16-question form
performs equivalently to the long form and is generally preferred
(Jorm, 2004). The questions are intended to be answered by an
informant who has known the subject for more than ten years.
They address short-term and long-term memory, orientation in
time and space, financial awareness, learning, and executive skills.
Education, pre-morbid ability and language proficiency have little
impact on IQCODE scores (Jorm and Jacomb, 1989) but a partic-
ipant’s anxiety or depression may influence the assessment (Jorm,
2004).
One instrument not included in Cherbuin and colleagues
(2008) review is the AD8 questionnaire, which is a simple
8-question, informant-based, survey of memory, orientation,
judgment, and function. Among a sample with a 0.38 prevalence
of very mild dementia, endorsement of two or more AD8 items
provided sensitivity of 74%, and specificity of 86% for discrim-
inating between normal and impaired (Galvin et al., 2005). A
self-rated form of the AD8 discriminates individuals with demen-
tia from those without, especially for mild dementia; self-rated
AD8 was somewhat less effective at this differentiation than the
informant reported method (Galvin et al., 2007).
COMPUTERIZED TESTING
Technology assisted assessments (e.g., computer administered
cognitive batteries, tele-health visits) are rapidly advancing but
appropriate psychometric properties and normative data are
nascent. These technologies may have significant advantages for
older persons with limited mobility or health-care access, but
may also disadvantage older persons with limited experience and
expertise interacting with technology. There are distinct advan-
tages to using computerized assessment in research studies. Test
stimuli can be presented in a highly rigorous and reproducible
fashion, while both response patterns and response latency pat-
terns can be systematically recorded and analyzed. From the data-
management perspective, data are automatically tabulated and
stored for future use. In addition, large numbers of participants
can be easily screened without introducing human factors con-
cerns such as variability across multiple practitioners, examiner
bias, and inter-rater reliability.
However, there are also disadvantages associated with
computer-based assessments. Some computerized tests have not
been validated and do not meet established psychometric testing
standards. Participants with poor motor control, slowed reaction
time, or sensory deficits may be unnecessarily penalized when
attempting to solve computer generated tasks Individuals who are
not putting forth their best effort, lack motivation, or attempting
to feign cannot be easily differentiated from those who have gen-
uine cognitive impairments. Another consideration is that older
adults, many of whom have little or no experience using tech-
nology, are typically less comfortable with computerized testing
(Broglio et al., 2007). Although this latter issue will most likely
abate over the next decades, there will continue to be wide cultural
and socio-economic differences in familiarity with computers
which, in turn, may limit the generalizability and reproducibility
of findings from this method.
A major limitation of scores based on automated tabula-
tion of the subject’s responses is that the investigator/clinician
knows only whether the item was successfully passed or failed,
not how the problem was solved. Knowledge of the participant’s
approach can be critically important when the investigator is
trying to understand the reasons underlying task failure and
the emphasis is on obtaining information regarding different
cognitive profiles or identifying patterns of cognitive deficits
(Lezak, 1995). Although computerized tests are supposed to
measure the same abilities as pencil and paper tasks, they do
not necessarily provide comparable information. Furthermore,
contrary to expectation, computerized assessments do not neces-
sarily result in high test–retest reliability. Schatz and Browndyke
(2002) suggested that the automated presentation of stimuli,
combined with limited interaction between the examiner and
examinee provides such limited resemblance to traditional assess-
ment methods that the two forms of testing will never be truly
equivalent.
CONCLUSIONS
Human subjects research on cognitive aging is challenging.
Controlling for the many confounding factors increases the dif-
ficulty of recruitment, the complexity of data collection and anal-
ysis, and burden on participants, investigators, or both. Stricter
subject selection criteria for confounding factors such as demo-
graphics or concomitant disease may simplify the approach to a
specific research question about cognition in aging while simul-
taneously reducing the applicability of its results to end users like
practicing physicians and their patients with memory concerns.
Nonetheless, an investigator who understands the complicating
factors, as well as the strengths and weaknesses of specific assess-
ment methods, will be better positioned to generate the most
reproducible and meaningful results.
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